Sir,

We encountered a 66-year-old woman with bullous pemphigoid (BP) that developed on lichen sclerosus et atrophicus (LSA) lesions.

The patient suffered from LSA for 12 years. While LSA most commonly affects the vulval area, her LSA involved the trunk, extremities, and the anogenital skin.\[[@ref1]\] Topical treatment with corticosteroids and tacrolimus yielded limited success.

Tense bullae appeared on the sclerotic LSA lesions in the genital region 12 years after the diagnosis of LSA \[Figure [1a](#F1){ref-type="fig"} and [b](#F1){ref-type="fig"}\]. The bullous lesions spread to the skin on the abdomen and chest affected by LSA. Her serum BP antibody, BP180, was 46.9 U/ml (chemiluminescence enzyme immunoassay). Skin biopsies from her abdomen and genitalia revealed subepidermal cleft with predominant eosinophilic infiltration \[Figure [1c](#F1){ref-type="fig"} and [d](#F1){ref-type="fig"}\]. In the upper dermis, we noted pronounced edema and collagen homogenization \[Figure [1c](#F1){ref-type="fig"} and [e](#F1){ref-type="fig"}\]. Direct immunofluorescence study of the same specimens revealed linear deposits of immunoglobulin G in the basement membrane zone \[[Figure 1f](#F1){ref-type="fig"}\]. The above findings led to the diagnosis of BP arising on LSA. Oral prednisolone (PSL, 30 mg/day) was started. The bullous lesions improved quickly, and her autoantibodies became negative. The PSL dose was gradually tapered to 10 mg, and she suffered no relapse in 1 year.

![Tense bullae and erosions on white glossy sclerotic LSA lesions on the abdomen (a) and genitalia (b). (c) Skin biopsy revealed a subepidermal cleft and infiltration of numerous eosinophils (H and E, ×10). (d) Close-up view of the subepidermal cleft in [Figure 1c](#F1){ref-type="fig"} (H and E, ×200). (e) Close-up view of the upper dermis in [Figure 1c](#F1){ref-type="fig"} (H and E, ×200). Note pronounced edema and collagen homogenization in the upper dermis. (f) Direct immunofluorescence showed linear deposits of immunoglobulin G in the basement membrane zone (×200)](IJD-63-427-g001){#F1}

Although the etiology and pathogenesis of LSA are not fully understood, they are thought to be multifactorial with the involvement of autoimmune-related factors.\[[@ref2][@ref3][@ref4]\] Our review of the English literature found only three cases of BP associated with LSA.\[[@ref2][@ref3][@ref4][@ref5]\] Meyrick Thomas *et al*.\[[@ref2]\] who investigated autoimmune-related phenomena in 350 women with histologically confirmed LSA demonstrated that 21.5% had one or more autoimmune diseases including alopecia areata (9%), vitiligo (6%), hypothyroidism (6%), and BP (1%); 42% presented with an autoantibody. With respect to autoantibodies against BP antigens, Baldo *et al*.\[[@ref3]\] reported that the noncollagenous 16A domain of BP180 was a target for circulating T-cells in over 40% of their patients with vulval lichen sclerosus or lichen planus; 4 of 19 manifested associated autoantibodies to BP180. A lichen sclerosus cohort study of 149 patients revealed elevated anti-BP antibodies in 5 (3.4%), BP180 in 4, and BP230 in one patient.\[[@ref4]\] These studies suggested an immunogenetic connection between LSA and anti-BP autoantibodies. Ours was a rare case of BP with LSA and further studies to examine the pathological role of anti-BP autoantibodies produced in LSA patients who develop associated BP are needed.
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